Moses Jennifer K.
- SEC CIK
- 0001706667
No open-market purchases or sales filed in the past year.
Current role at each company
- VRDN Viridian Therapeutics, Inc.Directoras of Jul 2, 2026
- GTHX G1 Therapeutics, Inc.CFOas of Jan 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Moses Jennifer K. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GTHX G1 Therapeutics, Inc.
CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 (view filing) | Jan 4-5 | 1 day | Moses Jennifer K.CFO | SSale | −2.37K | $5.53 | −$13.1K | −3.9%57.8K after | 2 lots |
| Jan 5, 2022 (view filing) | Jan 5 | Same day | Moses Jennifer K.CFO | SSale | −1.45K | $10.61 | −$15.3K | −3.9%35.6K after |